We are live on ! Find out more
AERI

Aerie Pharmaceuticals

Delisted

AERI was delisted on the 18th of November, 2022.

98 hedge funds and large institutions have $641M invested in Aerie Pharmaceuticals in 2014 Q4 according to their latest regulatory filings, with 34 funds opening new positions, 28 increasing their positions, 25 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

183% more first-time investments, than exits

New positions opened: 34 | Existing positions closed: 12

56% more capital invested

Capital invested by funds: $410M → $641M (+$231M)

50% more funds holding in top 10

Funds holding in top 10: 23 (+1)

29% more funds holding

Funds holding: 7698 (+22)

12% more repeat investments, than reductions

Existing positions increased: 28 | Existing positions reduced: 25

Holders
98
Holders Change
+22
Holders Change %
+28.95%
% of All Funds
2.61%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.08%
New
34
Increased
28
Reduced
25
Closed
12
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Macquarie Group
51
Macquarie Group
Australia
$1.01M +$49.5K +1,951 +6%
TRSOTSOK
52
Teachers Retirement System of the State of Kentucky
Kentucky
$975K
NFA
53
Nationwide Fund Advisors
Ohio
$889K -$1.85K -73 -0.2%
BIM
54
BlackRock Investment Management
Delaware
$875K -$15.5K -611 -2%
Neuberger Berman Group
55
Neuberger Berman Group
New York
$802K +$697K +27,500 New
PC
56
Polar Capital
United Kingdom
$742K +$223K +8,794 +53%
HLA
57
Hamilton Lane Advisors
Pennsylvania
$685K -$979K -38,605 -62%
CS
58
Credit Suisse
Switzerland
$674K +$585K +23,067 New
Deutsche Bank
59
Deutsche Bank
Germany
$669K +$323K +12,731 +124%
Bank of America
60
Bank of America
North Carolina
$668K -$32.3K -1,272 -5%
Point72 Asset Management
61
Point72 Asset Management
Connecticut
$581K +$505K +19,900 New
California State Teachers Retirement System (CalSTRS)
62
California State Teachers Retirement System (CalSTRS)
California
$569K +$2.1K +83 +0.4%
ARTA
63
A.R.T. Advisors
New York
$561K +$488K +19,226 New
ProShare Advisors
64
ProShare Advisors
Maryland
$529K +$460K +18,139 New
Swiss National Bank
65
Swiss National Bank
Switzerland
$514K +$446K +17,600 New
Morgan Stanley
66
Morgan Stanley
New York
$490K -$69.4K -2,735 -14%
AQR Capital Management
67
AQR Capital Management
Connecticut
$476K +$413K +16,300 New
NERM
68
New England Research & Management
Illinois
$474K +$411K +16,225 New
Charles Schwab
69
Charles Schwab
California
$468K
TA
70
Teachers Advisors
New York
$448K
RSS
71
Rosenblum Silverman Sutton
California
$356K +$309K +12,200 New
PPA
72
Parametric Portfolio Associates
Washington
$301K +$261K +10,310 New
MLICM
73
Metropolitan Life Insurance Company (MetLife)
New York
$264K
TAM
74
Tocqueville Asset Management
New York
$237K +$206K +8,112 New
RhumbLine Advisers
75
RhumbLine Advisers
Massachusetts
$234K +$203K +8,020 New

AERI Hedge Fund Activity: Q4 2014 in Review

98 of the 3,751 institutional investors tracked by Wall St. Rank reported a position in Aerie Pharmaceuticals (AERI) for Q4 2014, worth a combined $641M — up 56% from $410M a quarter earlier.

Buyers outnumbered sellers: 34 funds opened new AERI positions and 12 closed out — a net gain of 22 holders — while 28 added to existing stakes and 25 trimmed.

The largest buyer was Jennison Associates, adding an estimated $54.2M. The largest seller was TPG Group Holdings (SBS) Advisors, cutting an estimated $33M.

  • 98 institutional investors held Aerie Pharmaceuticals (AERI) as of Q4 2014, up from 76 in Q3 2014.
  • Funds reported $641M of Aerie Pharmaceuticals stock for Q4 2014, up 56% quarter-over-quarter.
  • 34 funds opened new Aerie Pharmaceuticals positions in Q4 2014 and 12 closed out, a net change of +22 holders.
  • The largest Aerie Pharmaceuticals buyer in Q4 2014 was Jennison Associates, an estimated $54.2M added.
  • The largest Aerie Pharmaceuticals seller in Q4 2014 was TPG Group Holdings (SBS) Advisors, an estimated $33M sold.

Based on aggregated 13F filings for Q4 2014.